Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening |
| |
| Authors: | Robert A. Smith PhD Kimberly S. Andrews BA Durado Brooks MD MPH Stacey A. Fedewa PhD MPH Deana Manassaram‐Baptiste PhD MPH Debbie Saslow PhD Otis W. Brawley MD Richard C. Wender MD |
| |
| Affiliation: | 1. Vice President, Cancer Screening, Cancer Control Department, American Cancer Society, Atlanta, GA;2. Director, Cancer Control Department, American Cancer Society, Atlanta, GA;3. Managing Director, Cancer Control Intervention, Cancer Control Department, American Cancer Society, Atlanta, GA;4. Director for Risk Factor Screening and Surveillance, Department of Epidemiology and Research Surveillance, American Cancer Society, Atlanta, GA;5. Senior Director, HPV Related and Women's Cancer, Cancer Control Department, American Cancer Society, Atlanta, GA;6. Chief Medical Officer, American Cancer Society, Atlanta, GA;7. Chief Cancer Control Officer, American Cancer Society, Atlanta, GA |
| |
| Abstract: | Answer questions and earn CME/CNE Each year, the American Cancer Society publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates, and select issues related to cancer screening. In this issue of the journal, the authors summarize current American Cancer Society cancer screening guidelines, describe an update of their guideline for using human papillomavirus vaccination for cancer prevention, describe updates in US Preventive Services Task Force recommendations for breast and colorectal cancer screening, discuss interim findings from the UK Collaborative Trial on Ovarian Cancer Screening, and provide the latest data on utilization of cancer screening from the National Health Interview Survey. CA Cancer J Clin 2017;67:100–121. © 2017 American Cancer Society. |
| |
| Keywords: | American Cancer Society diagnosis mass screening neoplasms prevention and control |
|
|
